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follow-up CAT scans, we could miss some of them unless they
developed symptoms related to the event.
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Dr Roy K. Greenberg (Cleveland, Ohio). With respect to
your discussion on incidents, were they calculated on a per-device
basis or a per-patient basis?
Dr Karthikeshwar Kasirajan. Per-device basis. We had no
way of calculating it per patient; because we could account for how
many devices were implanted during the study period, but we did
not have data on howmany patients actually received these devices.
We also did that because some patients had two devices and
you could have an invagination on the second or the distal device.
So, it was more of a per-device event and not a per-patient event.
Dr Greenberg. I found the data you presented really interest-
ing with respect to the etiology and the timing in terms of the
occurrence, but the incidence is still a troubling thing because only
30% of the patients are symptomatic. We really don’t know what
the incidence is; we just know what you’ve told us in terms of the
timing, which is very helpful.
Dr Kasirajan. That’s right. So, if patients don’t come forDr Piergiorgio Cao (Rome, Italy). It seems that the majority
f your failures were due to excessive oversizing. Can you give us
ome insight about the fraction of patients with this problem due
o excessive oversizing versus patients with the bird beak effect that
an be improved with the new c-TAG?
Dr Kasirajan. In all patients on whom we have imaging
tudies, at least which were provided to us, all of them were out of
he instructions for use for their sizing. This event was most
ommonly seen in trauma patients and dissections; the oversizing
n trauma patients was 36% and in dissections, it was 20%. But, you
re now talking about oversizing to the proximal neck, so if you
ake a dissection patient, typically there is a dramatic oversizing in
he true lumen distally. So, all of them were oversized beyond the
nstructions for use, which is 20%. We didn’t have any isolated
ompression, just related bird-beaking events.
And currently, the c-TAG has been approved in Europe and
hey have close to 2500 implants with no compression events
eported to date. So, I do think it’s a matter of oversizing more
han anything else as the causation.
